ChyronHego 10Q 2005 Q2 Quarterly report

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

FORM 10-Q

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF
THE SECURITIES EXCHANGE ACT OF 1934

For the Quarterly Period Ended June 30, 2005

Commission File Number 1-9014

Chyron Corporation

(Exact name of registrant as specified in its charter)

New York		11-2117385
(State or other jurisdiction of incorporation or organization)		(IRS Employer Identification No.)
5 Hub Drive, Melville, New York		11747
(Address of principal executive offices)		(Zip Code)
(631) 845-2000
(Registrant's telephone number, including area code)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports) and (2) has been subject to such filing requirements for the past 90 days.

Yes

Indicate by check mark whether the registrant is an accelerated filer (as defined in Rule 12b-2 of the Act).

Yes

Indicate the number of shares outstanding of each of the issuer's classes of common stock, as of the latest practical date.

Common Stock $.01 Par Value - 41,343,349 as of August 1, 2005

This document consists of 22 pages

CHYRON CORPORATION

INDEX

PART I	FINANCIAL INFORMATION	Page

Item 1.	Financial Statements
	Consolidated Balance Sheets as of June 30, 2005 (unaudited) and
	December 31, 2004	3

	Consolidated Statements of Operations (unaudited) for the Three
	Months ended June 30, 2005 and 2004	4

	Consolidated Statements of Operations (unaudited) for the Six
	Months ended June 30, 2005 and 2004	5

	Consolidated Statements of Cash Flows (unaudited) for the Six
	Months ended June 30, 2005 and 2004	6

	Notes to Consolidated Financial Statements (unaudited)	7

Item 2.	Management's Discussion and Analysis of Financial Condition
	and Results of Operations	14

Item 3.	Quantitative and Qualitative Disclosures About Market Risk	20

Item 4.	Controls and Procedures	20

PART II	OTHER INFORMATION

Item 1.	Legal Proceedings	21

Item 4.	Submission of Matters to a Vote of Security Holders	21

Item 6.	Exhibits	22

CHYRON CORPORATION
CONSOLIDATED BALANCE SHEETS
(In thousands, except share amounts)

	Unaudited
	June 30,	December 31,
ASSETS	2005	2004
Current assets:
Cash and cash equivalents	$ 723	$2,855
Accounts receivable, net	3,907	3,388
Inventories, net	3,354	2,570
Prepaid expenses and other current assets	337	718
Total current assets	8,321	9,531

Property and equipment, net	732	745
Other assets	20	29
TOTAL ASSETS	$9,073	$10,305

LIABILITIES AND SHAREHOLDERS' DEFICIT

Current liabilities:
Accounts payable and accrued expenses	$3,737	$3,215
Convertible debentures	1,282	1,239
Deferred revenue	829	934
Pension liability	286	362
Capital lease obligations	2	8
Total current liabilities	6,136	5,758

Convertible debentures	2,775	3,979
Pension liability	1,722	1,664
Other liabilities	201	225
Total liabilities	10,834	11,626

Commitments and contingencies

Shareholders' deficit:
Preferred stock, par value without designation
Authorized - 1,000,000 shares, issued - none
Common stock, par value $.01
Authorized - 150,000,000 shares
Issued and outstanding - 41,343,349 at June 30, 2005 and
41,326,016 at December 31, 2004	413	413
Additional paid-in capital	71,973	71,968
Accumulated deficit	(74,146)	(73,701)
Accumulated other comprehensive income	(1)	(1)
Total shareholders' deficit	(1,761)	(1,321)
TOTAL LIABILITIES AND SHAREHOLDERS' DEFICIT	$ 9,073	$10,305

See Notes to Consolidated Financial Statements

CHYRON CORPORATION
CONSOLIDATED STATEMENTS OF OPERATIONS
AND COMPREHENSIVE INCOME/LOSS
THREE MONTHS ENDED JUNE 30, 2005 AND 2004
(In thousands, except per share amounts)
(Unaudited)

	2005	2004

Net sales	$5,782	$4,852
Cost of products sold	1,996	1,858
Gross profit	3,786	2,994

Operating expenses:
Selling, general and administrative	3,216	2,524
Research and development	683	839

Total operating expenses	3,899	3,363

Operating loss	(113)	(369)

Interest expense	(53)	(92)

Interest income	22	22

Other expense, net	(25)	(5)

Net loss	$(169)	$ (444)

Net loss per common share - basic and diluted	$(0.00)	$(0.01)

Weighted average shares outstanding - basic and diluted	41,343	40,755

Comprehensive loss:
Net loss	$(169)	$(444)
Other comprehensive income:
Foreign currency translation gain		2

Total comprehensive loss	$(169)	$(442)

See Notes to Consolidated Financial Statements

CHYRON CORPORATION
CONSOLIDATED STATEMENTS OF OPERATIONS

AND COMPREHENSIVE INCOME/LOSS
SIX MONTHS ENDED JUNE 30, 2005 AND 2004
(In thousands, except per share amounts)
(Unaudited)

	2005	2004

Net sales	$11,757	$10,612
Cost of products sold	4,472	4,100
Gross profit	7,285	6,512

Operating expenses:
Selling, general and administrative	6,217	4,934
Research and development	1,409	1,744

Total operating expenses	7,626	6,678

Operating loss	(341)	(166)

Interest expense	(119)	(245)

Interest income	56	36

Other (expense) income, net	(41)	257

Net loss	$ (445)	$ (118)

Net loss per common share - basic and diluted	$(0.01)	$(0.00)

Weighted average shares outstanding - basic and diluted	41,336	40,736

Comprehensive loss:
Net loss	$(445)	$(118)
Other comprehensive income (loss):
Foreign currency translation gain		2
Unrealized loss on securities available for sale		(223)
Total comprehensive loss	$(445)	$(339)

See Notes to Consolidated Financial Statements

CHYRON CORPORATION
CONSOLIDATED STATEMENTS OF CASH FLOWS
SIX MONTHS ENDED JUNE 30, 2005 AND 2004
(In thousands)
(Unaudited)

	2005	2004
CASH FLOWS FROM OPERATING ACTIVITIES
Net loss	$(445)	$(118)
Adjustments to reconcile net loss to cash used in operating activities:
Depreciation and amortization	171	147
Non-cash settlement of interest liability	99	180
Amortization of debt issue costs	27	58
Gain on sale of securities		(224)
Other		4
Changes in operating assets and liabilities:
Accounts receivable	(519)	(570)
Inventories	(784)	(956)
Prepaid expenses and other assets	(65)	(137)
Accounts payable and accrued expenses	522	151
Other liabilities	(147)	25
Net cash used in operating activities	(1,141)	(1,440)

CASH FLOWS FROM INVESTING ACTIVITIES
Acquisitions of property and equipment	(158)	(206)
Receipt of proceeds from sale of Pro-Bel	428	415
Proceeds from sale of securities		289
Net cash provided by investing activities	270	498

CASH FLOWS FROM FINANCING ACTIVITIES
Payments of convertible debentures	(1,260)	(3,792)
Proceeds from exercise of stock options	5
Payments of capital lease obligations	(6)	(6)
Net cash used in financing activities	(1,261)	(3,798)

Change in cash and cash equivalents	(2,132)	(4,740)
Cash and cash equivalents at beginning of period	2,855	6,968
Cash and cash equivalents at end of period	$ 723	$ 2,228

See Notes to Consolidated Financial Statements

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(UNAUDITED)

1.BASIS OF PRESENTATION

General

In the opinion of management of Chyron Corporation (the "Company" or "Chyron"), the accompanying unaudited consolidated interim financial statements reflect all adjustments (consisting of only normal recurring adjustments) necessary to present fairly the financial position of the Company as of June 30, 2005 and the consolidated results of its operations and its cash flows for the periods ended June 30, 2005 and 2004. The results of operations for such interim periods are not necessarily indicative of the results that may be expected for the year ending December 31, 2005. In addition, management is required to make estimates and assumptions that affect the amounts reported and related disclosures. Estimates, by their nature, are based on judgment and available information. Also, during interim periods, certain costs and expenses are allocated among periods based on an estimate of time expired, benefit received, or other activity associated with the periods. Accordingly, actual results could differ from those estimates. Certain information and footnote disclosures normally included in financial statements prepared in accordance with generally accepted accounting principles have been omitted pursuant to the rules and regulations of the Securities and Exchange Commission. For further information, refer to the consolidated financial statements and footnotes thereto included in the Company's Annual Report on Form 10-K for the year ended December 31, 2004. The December 31, 2004 figures included herein were derived from such audited consolidated financial statements.

Nature of Business

Chyron Corporation and its wholly-owned subsidiaries ("Chyron" or the "Company") is a supplier of character generators ("CG") and graphics hardware and software related products to the television industry. The Company develops, manufactures, markets and supports hardware and software products that enhance the presentation of live and pre-recorded video, audio and other data. Chyron's products are used in broadcast production facilities worldwide for applications including news, sports, weather and election coverage. The Company's graphics products create, manipulate, store, playback and manage content including 2D/3D text, logos, graphics, animations and video stills/clips. In January 2005, Chyron expanded its products through the introduction of its ChyTV product line, providing low-cost, easy to use graphics for microcasting and digital displays applications.

Liquidity

Our future growth and success will depend to a significant degree on the continued growth of various markets that use our products. We operate in a rapidly changing environment and must remain responsive to changes as they occur. In the event that revenues are significantly below 2005 forecasted revenues we believe we have the ability to reduce or delay discretionary expenditures, including capital purchases, and reduce headcount, according to our contingency plan so that we will have sufficient cash resources. However, there can be no assurance that we will be able to adjust our costs in sufficient time to respond to revenue and cash shortfalls, should that occur.

The long term success of the Company will be dependent on profitable operating results and the ability to raise additional capital should such additional capital be required. In the event the Company is unable to achieve expected goals of profitability or raise sufficient additional capital, if needed, we may have to scale back or eliminate certain parts of our operations.

In the event of a significant downturn in sales, we have a contingent restructuring plan that recommends, in the event it is necessary, to reduce and/or defer spending in staffing, travel, trade shows, professional fees, equipment, and bonuses, among other items. However, there can be no assurance we would be able to execute the plans in adequate time to provide a significant immediate or short-term benefit and if implemented, could have an adverse effect on our ability to conduct business.

We believe that cash on hand, net cash to be generated in the business, and availability under our line of credit, will be sufficient to meet our cash needs through mid April 2006 if we are able to achieve our planned results of operations and retain availability of credit under our line. Our line of credit with our lender expires April 14, 2006 and will be subject to renewal. The Company has Series C convertible debentures in the amount of $1.3 million that will mature on April 30, 2006. The Company is exploring the possibility of alternative sources of funds, should it appear they will be needed. which could include a private common or preferred equity placement, or a debenture private placement, in the fourth quarter of 2005 to first quarter of 2006. The amount of funds that the Company would seek in such a transaction has not been determined at this time but would take into consideration the Company's need for working capital and the $1.3 million of convertible debentures that will ma ture on April 30, 2006.

There can be no assurance we will be able to achieve our plan. Furthermore, there can be no assurance that our bank will permit us to borrow under our line of credit if we fail to meet financial covenants and other requirements of the agreement or that we will be able to raise additional capital, if needed. From the inception of our agreement with our U.S. bank and through June 30, 2005, the Company was in compliance with our covenants. However, as of July 31, 2005, the Company did not meet its tangible net worth requirement of $2 million by approximately $0.1 million for which we obtained a waiver. In addition, the bank has agreed to modify its agreement and reduce the tangible net worth requirements as stated in Note 6.

Net Income (Loss) Per Share

For the periods ending June 30, 2005 and 2004, common stock equivalents of 10.0 million and 10.7 million shares, respectively, were not included in the computation of diluted net loss per common share because their effect would have been antidilutive.

2.EQUITY BASED COMPENSATION

We account for our stock compensation plans in accordance with the provisions of Accounting Principles Board Opinion No. 25, "Accounting for Stock Issued to Employees" ("APB 25"), and its related interpretations, which requires that compensation cost be recognized on the date of grant for stock options issued based on the difference, if any, between the fair market value of our stock and the exercise price. Under this intrinsic value method prescribed under APB 25 there was no compensation expense recognized for the three and six month periods ended June 30, 2005 and 2004. We have adopted the disclosure requirements of SFAS 123, "Accounting for Stock-Based Compensation," as amended by SFAS No. 148, "Accounting for Stock-Based Compensation - Transition and Disclosure" which allows entities to continue to apply the provisions of APB 25 for transactions with employees and provides pro-forma earnings disclosures for employee stock grants as if the fair value based method of accounting in SFAS No. 123 had been applied to these stock grants. The following table illustrates the effect on net loss and net loss per common share if the fair value method had been applied (in thousands except per share amounts):

	Three Months		Six Months
	Ended June 30,		Ended June 30,
	2005	2004	2005	2004

Net loss	$(169)	$(444)	$(445)	$(118)
Total stock-based compensation
income determined under fair value
based method, net of related tax effects	(24)	(42)	(777)	(28)
Pro forma net loss	$(193)	$(486)	$(1,222)	$(146)
Loss per share:
Basic and diluted - as reported	$(0.00)	$(0.01)	$(0.01)	$(0.00)
Basic and diluted - pro forma	$(0.00)	$(0.01)	$(0.03)	$(0.00)

Pursuant to authorization received from the Board of Directors, on February 3, 2005 the Company accelerated the vesting of certain outstanding unvested stock options with an exercise price of greater than $0.47 per share. These options were originally scheduled to vest in equal increments at the end of each of the first, second and third years following their grant date. Options representing the right to purchase a total of 100,000 shares that were previously granted to non-employee Directors of the Board of Directors, and that would otherwise qualify for this acceleration, were excluded from the acceleration of vesting.

The Company accelerated these options in advance of the effective date of, and in anticipation of the detrimental earnings effect of, Statement of Financial Accounting Standards

No. 123 "Share-Based Payment" ("SFAS 123R"), which was issued in December 2004. SFAS 123R will require that beginning January 1, 2006 (originally July 1, 2005), the Company record as compensation expense in its statement of operations the value of employee stock options. Until the Company commences accounting for stock options under SFAS 123R in 2006, it will continue its practice of accounting for stock options in accordance with the provisions of APB 25. The Company's decision to accelerate the vesting of the options was due to its desire to avoid recording compensation expense for these options in its statement of operations in future years when these options were originally scheduled to vest. The financial effect in the first quarter of 2005 was to accelerate the pro forma compensation expense by $0.7 million and thereby avoid recording the compensation expense of $0.29 million in 2006 and $0.15 million in 2007 that would have been required once FAS 123R is implemented in January 2006. As a result of the acceleration of vesting, options to purchase 1,503,939 shares of the Company's common stock became immediately exercisable. The following table summarizes the accelerated stock options:

Exercise	Number of Option Shares Accelerated
Price	from Original Vesting in
	2005	2006	2007	Total
$0.67	0	400,611	400,611	801,222
0.62	73,333	73,333	73,334	220,000
0.51	0	1,500	1,500	3,000
0.48	159,905	159,906	159,906	479,717
	233,238	635,350	635,351	1,503,939

3.MARKETABLE SECURITY

The Company had an investment in equity securities of vizrt Ltd. that was sold in the first quarter of 2004 and resulted in a gain of $0.2 million which is included in other income.

4.INVENTORIES

Inventory, net is comprised of the following (in thousands):

	June 30,	December 31,
	2005	2004

Finished goods	$ 652	$ 777
Work-in-progress	766	466
Raw materials	1,936	1,327
	$3,354	$2,570

5.SUBORDINATED CONVERTIBLE DEBENTURES

	June 30,	December 31,
	2005	2004
	(In thousands)
Series C Convertible Debentures	$1,282	$2,478
Series D Convertible Debentures	2,775	2,740
	$4,057	$5,218

In late 2003 and early 2004, we closed on two exchange offers whereby previously outstanding Series A and B Debentures were exchanged for new Series C Subordinated Convertible Debentures ("Series C Debentures") and new Series D Subordinated Convertible Debentures ("Series D Debentures"). The Series C Debentures bear interest annually at 7%, payable in kind, and can be converted to common stock at a per share conversion price of $1.50. In March 2005, all holders of the Company's Series C Debentures agreed to an amendment that resulted in payment by the Company on March 31, 2005, of a total of $1.26 million, representing 50% of their principal and accrued interest balance on March 31, 2005. The amendment also provides an extension of the due date to April 30, 2006 for the remainder of the principal and accrued interest which total $1.28 million at June 30, 2005. All other original terms of the Series C Debentures remain the same. The Series D Debentures, which total $2.8 million, bear interest annually at 8%, payable in kind, will mature December 31, 2006 and carry a per share conversion price of $0.65.

6.CREDIT FACILITY

The Company has a $2.5 million working capital line of credit with a U.S. bank which runs through April 14, 2006. The Company has the ability to borrow on a revolving credit basis based on levels of eligible accounts receivable. At June 30, 2005 and December 31, 2004 available borrowings on this basis were $2.2 million and $1.6 million, respectively. Interest will be payable at prime +1.5%, where prime is a minimum 4%, and we will be required to maintain certain levels of tangible net worth and cash or availability of $0.5 million. The lender defines tangible net worth ("TNW") as total assets less total liabilities, excluding subordinated convertible debentures, and 85% of the proceeds from the issuance of any new equity securities. The TNW requirement is $1.5 million at the end of April and May 2005, $3.0 million at the end of September and December 2005 and March 2006, and $2.0 million at the end of all other months. As is usual and customary in such lending agreements, our ag reement contains certain non-financial requirements such as required periodic reporting to the bank and various representations and warranties. From the inception of our agreement with our U.S. bank and through June 30, 2005 we have been in compliance with our financial and non-financial covenants. However, as of July 31, 2005, the Company did not meet its tangible net worth requirement of $2 million by approximately $0.1 million for which we obtained a waiver. In addition, the bank has agreed to modify its agreement to reduce the TNW requirement to $1.5 million at months ending August, October and November and $2.0 million at September and December. The TNW requirements for 2006 will remain unchanged. Throughout 2004 and 2005, there was no outstanding indebtedness under this line of credit or with any financial institution.

7.BENEFIT PLANS

The net periodic benefit cost is follows (in thousands):

	Three Months Ended		Six Months Ended
	June 30,		June 30,
	2005	2004	2005	2004
Service cost	$ 74	$ 71	$148	$142
Interest cost	42	37	84	74
Expected return on plan assets	(31)	(27)	(62)	(54)
Amortization of prior service cost	(9)	(9)	(18)	(18)
Amortization of prior gain	(2)	(14)	(4)	(28)
	$ 74	$ 58	$148	$116

Currently, our policy is to fund the minimum contributions required under the Employee Retirement Income Security Act. For the three and six month periods ended June 30, 2005, we made contributions of $0.09 million and $0.18 million, respectively, to the Pension Plan. We expect to contribute $0.3 million over the next twelve months.

The Company is also evaluating a freeze of the Pension Plan in order to reduce the growth of the Plan's liabilities while continuing to make contributions in order to reduce the unfunded liability of the Plan which approximates $2 million at June 30, 2005.

8.GEOGRAPHIC INFORMATION

The details of the Company's geographic sales are as follows (in thousands):

	Three Months Ended		Six Months Ended
	June 30,		June 30,
	2005	2004	2005	2004
United States	$4,219	$3,487	$9,184	$8,061
Germany	312	231	715	343
Canada	147	166	321	368
Other	1,104	968	1,537	1,840

9.PRODUCT WARRANTY

We provide product warranties for our various products, typically for one year. We establish our reserves based on historical data, taking into consideration specific product information. The following table sets forth the movement in the warranty reserve (in thousands):

	Three Months Ended		Six Months Ended
	June 30,		June 30,
	2005	2004	2005	2004
Balance at beginning of period	$ 50	$ 50	$ 50	$ 50
Accruals	(3)	(63)	13	(190)
Warranty services provided	3	63	(13)	190
	$ 50	$ 50	$ 50	$ 50

10.RECENT ACCOUNTING PRONOUNCEMENTS

In December 2004, the FASB issued FAS No. 123R, "Share-Based Payment." FAS No. 123R supercedes APB No. 25, FAS No. 123, as amended by FAS No. 148, and related interpretations. Under FAS No. 123R, compensation cost is measured at the grant date based on the estimated fair value of the award and is required to be recognized as compensation expense over the vesting period. FAS No 123R will be effective for the Company as of January 1, 2006.

Pursuant to authorization received from the Board of Directors, on February 3, 2005, the Company accelerated the vesting of certain outstanding unvested stock options with an exercise price of greater than $0.47 per share. The Company accelerated these options in advance of the original July 1, 2005 effective date of, and in anticipation of the detrimental earnings effect of SFAS 123R. The Company's decision to accelerate the vesting of the options was due to its desire to avoid recording compensation expense for these options in its statement of operations in future years when these options were originally scheduled to vest. Note 2 to the Company's consolidated financial statements presents the pro forma net loss the Company would have recognized had compensation costs for the Company's incentive compensation plans been determined consistent with FAS No. 123. Also included in Note 2 is the financial effect of the Q1 2005 acceleration of such options.

Based on grants that are currently outstanding and the elimination of the expense related to the accelerated vesting, the Company does not believe that the adoption of this standard will have a material impact on its financial position or results of operations. However, depending on the amount of options granted in the future, and their estimated value, both of which are unknown at this time, the adoption of this standard in the first quarter of 2006 could have a material impact on the Company's results of operations and financial position.

Item 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL
CONDITION AND RESULTS OF OPERATIONS

From time to time, including in this Quarterly Report on Form 10-Q, we may publish forward-looking statements relating to such matters as anticipated financial performance, business prospects, technological developments, changes in the industry, new products, research and development activities and similar matters. The Private Securities Litigation Reform Act of 1995 provides a safe harbor for such forward-looking statements. In order to comply with the terms of the safe harbor, we note that a variety of factors could cause our actual results to differ from the anticipated results or other expectations expressed in our forward-looking statements. The risks and uncertainties that may affect the operations, performance, development and results of our business include, without limitation, the following: product concentration in a mature market, dependence on the emerging digital market and the industry's transition to DTV and HDTV, consumer acceptance of DTV and HDTV, resistance within the b roadcast or cable industry to implement DTV and HDTV technology, use and improvement of the Internet, new technologies that could render certain Chyron products to be obsolete, a highly competitive environment, competitors with significantly greater financial resources, new product introductions by competitors, seasonality, fluctuations in quarterly operating results, ability to maintain adequate levels of working capital, viability of the OTC Bulletin Board as a trading platform, and expansion into new markets. Additional factors affecting future results, and which are described in more detail in our Annual Report on Form 10-K for the year ended December 31, 2004, include:

We cannot assure you that we will reach profitability because we have a history of losses.

Our future operating results are likely to fluctuate and therefore may fail to meet expectations, which could cause our stock price to decline.

If we fail to successfully develop, introduce and sell new products, we may be unable to compete effectively in the future.

If we are unable to keep up with rapid change in our industry, our business will not grow.

We expend substantial resources in developing and selling our products, and we may be unable to generate significant revenue as a result of these efforts.

Our customers may cancel or change their product plans after we have expended substantial time and resources in the design of their products.

If the digital video market does not grow, we will be unable to increase our revenues.

If the introduction of our new digital signage products does not produce as expected, then there will be a negative impact on revenue, earnings and cash flows.

We will be unable to compete effectively if we fail to anticipate product opportunities based upon emerging technologies and standards and fail to develop products that incorporate these technologies and standards.

We may not successfully develop strategic relationships that may be important to our business.

We operate in a highly competitive environment and industry and we may lack resources needed to capture increased market share.

We may encounter periods of industry-wide surface mount components shortage, resulting in pricing pressure and a risk that we could be unable to fulfill our customers' requirements.

We depend upon one supplier for the software license of our Aprisa product.

We depend on a limited number of suppliers of surface mount components.

If we fail to adequately forecast demand for our products, we may incur product shortages or excess product.

Problems in manufacturing our products, especially our new products, may increase the costs of our manufacturing process.

We may be unable to grow our business if the markets in which we sell our products do not grow.

Our business will suffer if our systems fail or become unavailable.

In order to become profitable, we will need to offset the general pattern of declines and fluctuations in the prices of our products

We depend upon third party dealers to market and sell our products and they may discontinue sale of our products, fail to give our products priority or be unable to successfully market, sell and support our products.

Problems associated with international business operations could subject us to risks from financial, operational and political situations, and affect our ability to manufacture and sell our products.

We may be unable to accurately predict quarterly results which could adversely affect the trading price of our stock.

We may be unable to successfully grow our business if we fail to compete effectively with others to attract and retain key personnel.

We may not be able to protect our proprietary technology and may be sued for infringing on the rights of others.

We may not be able to successfully implement our contingency plan upon a decline in revenues.

We are uncertain of our ability to obtain additional financing or refinance existing obligations for our future needs, and liquidity issues have and may continue to increase our cost of capital.

The TV broadcast industry has historically expected substantial marketing expenses.

We sell hardware and software service agreements to our customers that may become onerous because of product problems or the age of our products.

Our warranties on products may prove insufficient and could cause us unexpected costs.

If a new law or regulation is created pertaining to the telecommunications and television industries it could cause our customers to suffer and impede our ability to increase profits.

Our principal stockholders have significant voting power and may vote for actions that may not be in the best interests of all our stockholders.

We have not issued dividends on our common stock for over thirteen years and do not anticipate doing so in the foreseeable future.

The price of our common stock may be volatile.

An increase in the number of shares of our common stock outstanding could reduce the price of our common stock.

We have various mechanisms in place to discourage takeover attempts, which may reduce or eliminate your ability to sell your shares for a premium in a change of control transaction.

It may be difficult to sell your shares and the value of your investment may be reduced because our common stock has experienced low trading volumes on the OTC Bulletin Board and currently lacks public market research analyst coverage.

Results of Operations

This discussion should be read in conjunction with the Consolidated Financial Statements including the Notes thereto.

Comparison of the Three and Six Months Ended June 30, 2005 and 2004

Revenues for the quarter ended June 30, 2005 were $5.8 million, an increase of $0.9 million, or 18% from the $4.9 million reported for the second quarter of 2004. Revenues for the six months ended June 30, 2005 were $11.8 million, an increase of $1.2 million or 11% from the $10.6 million reported for the first six months of 2004.

Revenues derived from U.S. customers were $4.2 million in the second quarter of 2005 as compared to $3.5 million in the second quarter of 2004. Revenues derived from international customers were $1.6 million in the second quarter of 2005 as compared to $1.4 million in the second quarter of 2004. Year to date revenues in the U.S. were $9.2 million in 2005 and $8.1 million in 2004. Year to date international revenues were $2.6 million in 2005 and $2.5 million in 2004. Domestic and international revenues in all periods in 2005 increased in comparison to 2004 amounts as a result of sales of Duet HyperX systems which can be configured as HD, SD or a combination of both, offering a highly flexible and scalable migration path to high definition broadcasting. Also contributing to this growth is the continued acceptance of Duet LEX by major sports programmers. Sales of our new microcasting and digital displays product line accounted for 1% of the increase in the six month period in 2005.

Gross margins for the second quarter of 2005 increased to 65% from 62% in the comparable quarter in 2004. Gross margins for the six month periods in 2005 and 2004 were 62% and 61%, respectively. Improvements in gross margins are a result of product mix and lower overhead costs in total and greater absorption from overall increased sales levels in 2005 over 2004.

Selling, general and administrative (SG&A) expenses increased by $0.7 million, to $3.2 million in the quarter ended June 30, 2005 compared to $2.5 million in the second quarter of 2004. SG&A expenses increased by $1.3 million, to $6.2 million in the first six months of 2005 compared to $4.9 million for the first six months of 2004. The primary reason contributing to the increase in SG&A expenses in the three and six month periods were expenses attributable to the rollout of the ChyTV product line of $0.3 million and $0.6 million, respectively. Other increases in the second quarter of 2005 were attributable to $0.1 million of consulting services for Sarbanes-Oxley compliance and other systems consulting services, $0.1 million of increased employee benefit costs, $0.1 million for costs associated with trades shows and $0.1 million of other selling expenses, largely resulting from the costs of overseas sales offices. Increases were also realized in the six month period in 2005 f or similar reasons and totaled $0.1 million for consulting services for Sarbanes-Oxley compliance and other systems consulting, $0.2 million of increased employee benefit costs, severance costs of $0.1 million, $0.1 million of trade show costs and $0.2 million of other selling expenses, including the costs of overseas sales offices.

Research and development (R&D) costs in the second quarter of 2005 of $0.7 million decreased by $0.1 million compared to the quarter ended June 30, 2004. R&D costs decreased by $0.3 million, to $1.4 million in the first six months of 2005, compared to $1.7 million for the first six months of 2004. Reductions in spending in the three and six month periods in 2005 are attributable to lower project materials costs, reduced services performed by outside consultants and lower personnel costs.

Interest expense in the second quarter of 2005 approximated $0.05 million as compared to $0.1 million in the second quarter of 2004. Interest expense in the first six months of 2005 was $0.1 million as compared to $0.2 million in 2004. This is a direct result of the combination of lower balances and lower interest rates on the underlying debt instruments. In the fourth quarter of 2003 and first quarter of 2004, we closed on two exchange offers which resulted in the retirement of approximately $6 million of Series A and B debentures, with the balance exchanged for Series C and D debentures which carry a lower rate of interest.

The components of other income (expense), net are as follows (in thousands):

	Three Months		Six Months
	Ended June 30,		Ended June 30,
	2005	2004	2005	2004

Foreign exchange transaction (loss) gain	$(39)	$ (5)	$(69)	$ 33
Gain on sale of securities				224
Other	14		28
	$(25)	$ (5)	$(41)	$257

Liquidity and Capital Resources

At June 30, 2005, we had cash on hand of $0.7 million and working capital of $2.2 million.

During the six months ended June 30, 2005, net cash of $1.1 million was used by operations and $1.26 million was used to retire a portion of our Series C Debentures. The utilization of cash from operations was driven by the net loss in the six month period, an increase in receivables from sales that were realized late in the quarter, and therefore not yet collectable, an increase in inventory, partly resulting from the new digital signage product line, and partially offset by $0.5 million from the increase in accounts payable and accrued expenses.

In March 2005, we amended the Series C Debentures such that half of the principal and accrued interest at March 31, 2005, became due and payable on that date and the remaining half of the principal, plus accrued interest through April 30, 2006, becomes due and payable on that date. As per the amended Series C Debenture terms, on March 31, 2005, $1.26 million was paid to holders and the remaining principal of $1.28 million, plus accrued interest, will be due on April 30, 2006. The Series D Debentures, which total $2.8 million, and bear interest annually at 8%, payable in kind, will mature December 31, 2006.

The Company received $0.4 million in May 2005 which represents the final payment of the proceeds from the sale of Pro-Bel.

We provide graphics products to the broadcast industry for use in digital television. Our future growth and success will depend to a significant degree on the continued growth of various markets that use our products. We operate in a rapidly changing environment and must remain responsive to changes as they occur. In the event that revenues are significantly below 2005 forecasted revenues we believe we have the ability to reduce or delay discretionary expenditures, including capital purchases, and reduce headcount, according to our contingency plan so that we will have sufficient cash resources. However, there can be no assurance that we will be able to adjust our costs in sufficient time to respond to revenue and cash shortfalls, should that occur.

Recent Accounting Pronouncements

In December 2004, the FASB issued FAS No. 123R, "Share-Based Payment." FAS No. 123R supercedes APB No. 25, FAS No. 123, as amended by FAS No. 148, and related interpretations. Under FAS No. 123R, compensation cost is measured at the grant date based on the estimated fair value of the award and is required to be recognized as compensation expense over the vesting period. FAS No. 123R will be effective for the Company as of January 1, 2006.

Pursuant to authorization received from the Board of Directors, on February 3, 2005, the Company accelerated the vesting of certain outstanding unvested stock options with an exercise price of greater than $0.47 per share. The Company accelerated these options in advance of the original July 1, 2005 effective date, and in anticipation of the detrimental earnings effect of SFAS 123R. The Company's decision to accelerate the vesting of the options was due to its desire to avoid recording compensation expense for these options in its statement of operations in future years when these options were originally scheduled to vest. Note 2 to the Company's consolidated financial statements presents the pro forma net loss the Company would have recognized had compensation costs for the Company's incentive compensation plans been determined consistent with FAS No. 123. Also included in Note 2 is the financial effect of the Q1 2005 acceleration of such options.

Item 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT
MARKET RISK

We are exposed to foreign currency and exchange risk in the normal course of business related to investments in our foreign subsidiaries and sales to foreign customers. For the three months ended June 30, 2005 and 2004, sales to foreign customers were 27% and 28% of total sales, respectively. For the six month period ended June 30, 2005 and 2004, sales to foreign customers were 22% and 24%, respectively. All sales generated outside of the U.S. are denominated in British Pounds Sterling, Euros or U.S. Dollars. The Company does not hedge any of its foreign currency exposure.

The net impact on earnings of foreign exchange transactions was a loss of $0.04 million in the three month period ended June 30, 2005 and a minimal loss in the three month period ended June 30, 2004. The net impact of foreign exchange transactions in the six months ended June 30, 2005 and 2004 were a loss of $0.07 million and a gain of $0.03 million, respectively. We record translation gain or loss as a separate component of other comprehensive income or loss in shareholders' equity (deficit).

Additionally, we are potentially exposed to interest rate risk with respect to borrowings under our line of credit which would carry a variable interest rate. Rates that affect the variable interest on this debt include the Prime Rate. Throughout 2004 and 2005, there was no outstanding indebtedness with variable interest rates. We have evaluated the foreign currency exchange risk and interest rate risk and believe that our exposure to these risks are not material to our near-term financial position, earnings or cash flows.

Item 4. CONTROLS AND PROCEDURES

As of June 30, 2005, an evaluation was performed under the supervision and with the participation of the Company's management, including the Chief Executive Officer ("CEO") and Chief Financial Officer ("CFO"), of the effectiveness of the design and operation of the Company's disclosure controls and procedures. Based on that evaluation, the Company's management, including the CEO and CFO, concluded that the Company's disclosure controls and procedures were effective as of June 30, 2005. There have been no significant changes in the Company's internal control over financial reporting during the most recent quarter that have materially affected, or are reasonably likely to materially affect, the Company's internal control over financial reporting.

PART II. OTHER INFORMATION

ITEM 1. LEGAL PROCEEDINGS

The Company from time to time is involved in routine legal matters incidental to its business. In the opinion of management, the ultimate resolution of such matters will not have a material adverse effect on the Company's financial position, results of operations or liquidity.

ITEM 4. SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS

Our Annual Meeting of Shareholders was held on May 18, 2005. The voting results were as follows:

Proposal Number 1: Election of Directors
	For	Against
Donald P. Greenberg	26,198,690	348,432
Roger Henderson	26,167,253	379,868
Christopher R. Kelly	26,179,104	368,017
Eugene M. Weber	26,183,961	363,160
Michael I. Wellesley-Wesley	26,186,768	360,354

Proposal Number 2: Amendment to the Company's 1999 Incentive Compensation Plan to Increase the Maximum Number of Authorized Shares by 2,000,000

For	Against	Abstain
11,368,356	852,296	472,570

Proposal Number 3: Amendment to the Company's 1999 Incentive Compensation Plan to Increase the Annual Stock Option Grant to Non-Employee Directors from 5,000 to 25,000 Shares

For	Against	Abstain
11,335,343	859,353	471,526

ITEM 6. EXHIBITS

Exhibit No.	Description of Exhibit
10.	Silicon Valley Bank Third Loan Modification Agreement dated August 12, 2005

31.1	Certification of Chief Executive Officer pursuant to Rule 13A-14(a) or 15D-14(a) of the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

31.2	Certification of Chief Financial Officer pursuant to Rule 13A-14(a) or 15D-14(a) of the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

32.1	Certification of Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

32.2	Certification of Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

		CHYRON CORPORATION
		(Registrant)


August 12, 2005		/s/ Michael Wellesley-Wesley
(Date)		Michael Wellesley-Wesley
		President and
		Chief Executive Officer

August 12, 2005		/s/ Jerry Kieliszak
(Date)		Jerry Kieliszak
		Chief Financial Officer and
		Senior Vice President

Positive
Negative
Uncertain
Constraining
Legalese
Litigious
Readability	H.S. sophomore Good

ChyronHego (CHYR) Inactive 10-Q2005 Q2 Quarterly report

Content analysis